IMR Press / EJGO / Volume 37 / Issue 3 / DOI: 10.12892/ejgo3080.2016

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Review
Replicating viruses for gynecologic cancer therapy
J.W. Park1 , M. Kim2,*
Show Less
1 Department of Obstetrics & Gynecology, Dankook University College of Medicine, Cheonan, South Korea
2 Department of Medical Science, Dankook University College of Medicine, Cheonan, South Korea
Eur. J. Gynaecol. Oncol. 2016, 37(3), 295–304; https://doi.org/10.12892/ejgo3080.2016
Published: 10 June 2016
Abstract

Despite advanced therapeutic treatments, gynecologic malignancies such as cervical and ovarian cancers are still the top ten leading cause of cancer death among women in South Korea. Thus a novel and innovative approach is urgently needed. Naturally occurring viruses are live, replication-proficient viruses that specifically infect human cancer cells while sparing normal cell counterparts. Since the serendipitous discovery of the naturally oncotropic virus targeting gynecologic cancer in 1920s, various replicating viruses have shown various degrees of safety and efficacy in preclinical or clinical applications for gynecologic cancer therapy. Cellular oncogenes and tumor suppressor genes, which are frequently dysregulated in gynecologic malignancies, play an important role in determining viral oncotropism. Published articles describing replicating, oncolytic viruses for gynecologic cancers are thoroughly reviewed. This review outlines the discovery of replication-proficient virus strains for targeting gynecologic malignancies, recent progresses elucidating molecular connections between oncogene/tumor suppressor gene abnormalities and viral oncotropism, and the associated preclinical/clinical implications. The authors would also like to propose future directions in the utility of the replicating viruses for gynecologic cancer therapy.
Keywords
Replicating virus
Oncolytic virus
Gynecologic cancer
Oncogenes
Tumor suppressor genes
Share
Back to top